Reaction
Philadelphia Positive Acute Lymphocytic Leukaemia reporting signals
As of the last recalculation, Philadelphia Positive Acute Lymphocytic Leukaemia appears in 160 FAERS reports alongside 3 co-occurring drug terms. The strongest observed disproportionality signal is DASATINIB (PRR 129.0).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Dasatinib | 30 | 129.0 | 129.1 |
| Imatinib | 14 | 113.1 | 113.2 |
| Blinatumomab | 8 | 104.9 | 105.0 |